The serendipitous discovery of the anticancer drug cisplatin cemented medicinal inorganic
chemistry as an independent discipline in the 1960s. Luminescent metal complexes have …

The unique chiral structure of DNA has been a source of inspiration for the development of a
new class of bio-inspired catalysts. The novel concept of DNA-based asymmetric catalysis …

A novel nanocomplex displaying single-excitation and dual-emission fluorescent properties
has been developed through a crown-like assembly of dye-encapsulated silica particles …

Synthetic oligonucleotides (ONs) are being investigated for various therapeutic and
diagnostic applications. The interest in ONs arises because of their capability to cause …

The complex [Cu (N9-ABS)(phen) 2]· 3.6 H2O, H2N9-ABS= N-(9H-purin-6-yl)
benzenesulfonamide and phen= 1, 10-phenanthroline, has been synthesized and then …

In recent decades, coordination polymers (CPs) constructed by metal ions/clusters as nodes
and organic linkers through coordination interactions, have expanded rapidly in both …

The development of synthetic agents able to hydrolytically cleave DNA with high efficiency
and selectivity is still a fascinating challenge. Over the years, many examples have been …

There is a growing interest in the cancer cell growth inhibitory effects of organotin (IV)
compounds and, accordingly, a new series of dimethyl-, di-(n-butyl)-, diphenyl-and chloro …

The fusion of homogeneous and enzymatic catalysis has recently drawn attention due to
reported novel activities and high selectivities. The incorporation of metal-catalysts into …

Apart from cisplatin and some derivatives successful metallopharmaceuticals are still scarce
in antitumour therapy. Although novel metal complexes have been investigated in preclinical …